JSCh
ELITE MEMBER
- Jun 9, 2011
- 13,245
- 2
- Country
- Location
Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature currently requires accessing the site using the built-in Safari browser.
China medical industry
- Thread starter TaiShang
- Start date
JSCh
ELITE MEMBER
- Jun 9, 2011
- 13,245
- 2
- Country
- Location
Chinese Tech Firm Debuts Five-Meter Fever-Finding Smart Helmet
TANG SHIHUA
DATE : FEB 26 2020/SOURCE : YICAI
Chinese Tech Firm Debuts Five-Meter Fever-Finding Smart Helmet(Yicai Global) Feb. 26 -- Chinese tech firm Kuang-Chi Technologies has developed a smart helmet that Covid-19 prevention and control staff can use to automatically pinpoint people running fevers.
The apparatus thus identifies and targets people who are high-risk for virus transmission in heavily-traveled public areas.
The artificial intelligence-based device looks much like a motorcycle helmet, and monitoring personnel wearing it can quickly measure the body temperatures of people passing in crowds within a range of three to five meters. The helmet emits both a visual and audio alert once it identifies someone with an elevated reading, Shanghai Observer reported.
The headgear can scan the body temperatures of hundreds of people and lock onto those with fever in less than two minutes. It also overcomes the difficulties of sniffing out abnormal temperatures in timely, accurate and effective manner in complex scenarios, the Zhejiang province-based firm stated, adding the entire process is highly efficient and occurs from a safe distance without any contact, and thus it is safe for both staffers and those surveyed.
A big general hospital with 10 of the instruments, a large business district with five to 10, and a subway station with up to three can detect and identify all people who pose a hazard in these areas, the firm estimates.
TANG SHIHUA
DATE : FEB 26 2020/SOURCE : YICAI
Chinese Tech Firm Debuts Five-Meter Fever-Finding Smart Helmet
The apparatus thus identifies and targets people who are high-risk for virus transmission in heavily-traveled public areas.
The artificial intelligence-based device looks much like a motorcycle helmet, and monitoring personnel wearing it can quickly measure the body temperatures of people passing in crowds within a range of three to five meters. The helmet emits both a visual and audio alert once it identifies someone with an elevated reading, Shanghai Observer reported.
The headgear can scan the body temperatures of hundreds of people and lock onto those with fever in less than two minutes. It also overcomes the difficulties of sniffing out abnormal temperatures in timely, accurate and effective manner in complex scenarios, the Zhejiang province-based firm stated, adding the entire process is highly efficient and occurs from a safe distance without any contact, and thus it is safe for both staffers and those surveyed.
A big general hospital with 10 of the instruments, a large business district with five to 10, and a subway station with up to three can detect and identify all people who pose a hazard in these areas, the firm estimates.
Stranagor
SENIOR MEMBER
- May 11, 2014
- 2,186
- -8
- Country
- Location
Sanxing Medical to Sell USD136 Million of Smart Meters Overseas
TANG SHIHUA
DATE : MAR 06 2020/SOURCE : YICAI
Sanxing Medical to Sell USD136 Million of Smart Meters Overseas
(Yicai Global) March 6 -- China's Ningbo Sanxing Medical Electric has penned three deals worth CNY949 million (USD136 million) to supply its smart meters overseas.
The largest of the agreements was a SEK733 million (USD77.6 million) contract with Sweden's Vattenfall Eldistribution, which has around 6 million customers in Northern Europe, Zhejiang province-based Sanxing said in a statement yesterday.
Shares in Sanxing [SHA:601567] had climbed 1.8 percent to CNY9 (USD1.29) as of the lunch break today, after hitting a near two-year high in the morning session.
The firm also penned a CNY325 million contract with Saudi Arabian integrated electrical equipment manufacturer Memf Electrical Industries, and a CNY84 million supply deal with Indonesia's national grid operator Perusahaan Listrik Negara Persero.
The agreements with Vattenfall and Memf are valid through 2024 while the deal in Indonesia is just for this year. Combined, the three contracts equate to nearly 16.2 percent of Sanxing's 2018 operating income.
https://yicaiglobal.com/news/sanxing-medical-to-sell-usd136-million-of-smart-meters-overseas
TANG SHIHUA
DATE : MAR 06 2020/SOURCE : YICAI
Sanxing Medical to Sell USD136 Million of Smart Meters Overseas
(Yicai Global) March 6 -- China's Ningbo Sanxing Medical Electric has penned three deals worth CNY949 million (USD136 million) to supply its smart meters overseas.
The largest of the agreements was a SEK733 million (USD77.6 million) contract with Sweden's Vattenfall Eldistribution, which has around 6 million customers in Northern Europe, Zhejiang province-based Sanxing said in a statement yesterday.
Shares in Sanxing [SHA:601567] had climbed 1.8 percent to CNY9 (USD1.29) as of the lunch break today, after hitting a near two-year high in the morning session.
The firm also penned a CNY325 million contract with Saudi Arabian integrated electrical equipment manufacturer Memf Electrical Industries, and a CNY84 million supply deal with Indonesia's national grid operator Perusahaan Listrik Negara Persero.
The agreements with Vattenfall and Memf are valid through 2024 while the deal in Indonesia is just for this year. Combined, the three contracts equate to nearly 16.2 percent of Sanxing's 2018 operating income.
https://yicaiglobal.com/news/sanxing-medical-to-sell-usd136-million-of-smart-meters-overseas
JSCh
ELITE MEMBER
- Jun 9, 2011
- 13,245
- 2
- Country
- Location
China-developed AI, CT system used in Kenya
Zhu Shenshen
17:26 UTC+8, 2020-03-23
Remote diagnostic meetings attended by global experts are used to fight against the coronavirus epidemic in Africa.
A China-developed artificial intelligence system which allows remote CT-image diagnosis of coronavirus infection is now being used in Kenyan hospitals.
Neusoft Medical and Kenyan hospitals such as Kenyatta National Hospital have launched the system, which includes CT scanning devices, a cloud imaging center and AI diagnosis capabilities.
Meanwhile, Neusoft Medical is conducting remote international diagnostic meetings with radiologists from Kenya, France, United Arab Emirates and China using the company's medical imaging cloud. Radiologists from Wuhan who joined the fight against the coronavirus shared their knowledge and successful experiences with doctors at Kenyatta National Hospital and Moi Teaching & Referral Hospital.
In recent years, Neusoft Medical’s devices and services have been used in 37 hospitals in Kenya. These hospitals are able to use AI-powered systems that can help them optimize work flow and diagnose COVID-19 accurately and quickly.
Source: SHINE Editor: Wang Yanlin
Zhu Shenshen
17:26 UTC+8, 2020-03-23
A China-developed artificial intelligence system which allows remote CT-image diagnosis of coronavirus infection is now being used in Kenyan hospitals.
Neusoft Medical and Kenyan hospitals such as Kenyatta National Hospital have launched the system, which includes CT scanning devices, a cloud imaging center and AI diagnosis capabilities.
Meanwhile, Neusoft Medical is conducting remote international diagnostic meetings with radiologists from Kenya, France, United Arab Emirates and China using the company's medical imaging cloud. Radiologists from Wuhan who joined the fight against the coronavirus shared their knowledge and successful experiences with doctors at Kenyatta National Hospital and Moi Teaching & Referral Hospital.
In recent years, Neusoft Medical’s devices and services have been used in 37 hospitals in Kenya. These hospitals are able to use AI-powered systems that can help them optimize work flow and diagnose COVID-19 accurately and quickly.
Source: SHINE Editor: Wang Yanlin
Stranagor
SENIOR MEMBER
- May 11, 2014
- 2,186
- -8
- Country
- Location
China's Dian Diagnostics Gets Green Light to Sell Covid-19 Testing Kits in EU
DOU SHICONG
DATE : MAR 23 2020/SOURCE : YICAI
China's Dian Diagnostics Gets Green Light to Sell Covid-19 Testing Kits in EU
(Yicai Global) March 23 -- Chinese genetics firm Dian Diagnostics Group and its collaborators have been granted approval to sell their 15-minute Covid-19 testing kit in the virus-stricken European Union.
The testing kit, co-developed by Hangzhou-based Dian, Shandong ThinkLab Biotechnology and genetic engineer Li Xiaokun, has obtained the EU's Conformite Europeene Certification, Dian announced on its website yesterday.
The kit tests for Covid-19 virus-specific antibodies immunoglobulin M and immunoglobulin G. It can detect the virus in its early, mid and late stages and can be used together with nucleic acid tests for better accuracy.
ThinkLab, in which Dian is an investor, is the kit's manufacturer and is currently churning out 100,000 units a day to meet demand both at home and abroad, Dian said.
China is donating and selling testing kits to more than 10 countries including Italy, the UK and the Netherlands, Lei Zhaozi, director of the Department of Science and Technology at China's Ministry of Education, said at a press conference on March 17.
Fourteen Covid-19 testing kits developed by Tsinghua University in Beijing and four other Chinese universities have gained the EU certification, according to incomplete statistics.
Li is president of Wenzhou Medical University and was elected an academician of the Chinese Academy of Engineering last November. He specializes in the research of genetically engineered protein drugs, engineering technology, new drug development, clinical application and translational medicine research.
DOU SHICONG
DATE : MAR 23 2020/SOURCE : YICAI
China's Dian Diagnostics Gets Green Light to Sell Covid-19 Testing Kits in EU
(Yicai Global) March 23 -- Chinese genetics firm Dian Diagnostics Group and its collaborators have been granted approval to sell their 15-minute Covid-19 testing kit in the virus-stricken European Union.
The testing kit, co-developed by Hangzhou-based Dian, Shandong ThinkLab Biotechnology and genetic engineer Li Xiaokun, has obtained the EU's Conformite Europeene Certification, Dian announced on its website yesterday.
The kit tests for Covid-19 virus-specific antibodies immunoglobulin M and immunoglobulin G. It can detect the virus in its early, mid and late stages and can be used together with nucleic acid tests for better accuracy.
ThinkLab, in which Dian is an investor, is the kit's manufacturer and is currently churning out 100,000 units a day to meet demand both at home and abroad, Dian said.
China is donating and selling testing kits to more than 10 countries including Italy, the UK and the Netherlands, Lei Zhaozi, director of the Department of Science and Technology at China's Ministry of Education, said at a press conference on March 17.
Fourteen Covid-19 testing kits developed by Tsinghua University in Beijing and four other Chinese universities have gained the EU certification, according to incomplete statistics.
Li is president of Wenzhou Medical University and was elected an academician of the Chinese Academy of Engineering last November. He specializes in the research of genetically engineered protein drugs, engineering technology, new drug development, clinical application and translational medicine research.
JSCh
ELITE MEMBER
- Jun 9, 2011
- 13,245
- 2
- Country
- Location
Trials likely for 1st homegrown superconducting cyclotron for proton therapy
By Liu Zhihua | chinadaily.com.cn | Updated: 2019-04-19
The superconducting cyclotron for proton therapy. [Photo provided to chinadaily.com.cn]
The 230 million electron volts superconducting cyclotron for proton therapy currently under development at the China Institute of Atomic Energy will likely become fully commissioned next year for clinical trials, making it the first of its kind in China, according to scientists with the institute.
The superconducting cyclotron is a mainstream core component of proton-based cancer therapy equipment that has increased in presence worldwide.
Compared with conventional radiotherapy, proton beams will only release a large percentage of radiation dose when reaching tumors, which means it will kill the cancer cells while leaving healthy cells intact.
中核集团
9月22日 22:07 来自 微博 weibo.com 已编辑
【#质子治癌国产化取得重大进展#！我国自主研发的超导回旋加速器质子束能量首次达到231MeV】 该设备由中核集团原子能院自主研发，旨在发展具有自主知识产权的新一代高剂量率、小型化精准放疗设备，突破国外在这一重大医疗装备领域的垄断地位，逐步实现我国恶性肿瘤、心脑血管疾病等重大疾病诊断和治疗的回旋加速器设备国产化，造福广大癌症患者。专家指出，这样的大型超导回旋加速器，除了用于质子治疗，在宇航器件、核心芯片研发和应用领域也有重要应用。为我国的核科学家点赞
![[中国赞]](/proxy.php?image=https%3A%2F%2Fimg.t.sinajs.cn%2Ft4%2Fappstyle%2Fexpression%2Fext%2Fnormal%2F6d%2F2018new_zhongguozan_org.png&hash=3807684d688858c1c2485114712e9ba3 "[中国赞]")
#走进新国企# #核你在一起# #神秘区域探访计划#
China National Nuclear Corporation
September 22, 22:07 from Weibo weibo.com Edited
[#Major progress made in the localization of proton cancer treatment#! China’s self-developed superconducting cyclotron proton beam energy reaches 231MeV for the first time]
This equipment is independently developed by the China Nuclear Group Atomic Energy Institute, aiming to develop a new generation of high-dose rate, miniaturized precision radiotherapy equipment with independent intellectual property rights; and break through foreign countries monopoly in the field of major medical equipment. This gradual realization for localization of cyclotron equipment for the diagnosis and treatment of major diseases such as malignant tumors and cardiovascular and cerebrovascular diseases in China, will benefit the majority of cancer patients.
Experts pointed out that such a large superconducting cyclotron, in addition to proton therapy, also has important applications in the development and application of aerospace devices, core chips.
JSCh
ELITE MEMBER
- Jun 9, 2011
- 13,245
- 2
- Country
- Location
Chinese medicine regulator to review EdiGene’s therapy for blood disorders
Source: Global Times Published: 2020/10/27 16:38:42
Pakistani patient suffering from thalassemia receives blood at a medical center on the World Thalassemia Day in Islamabad, Pakistan, on May 8, 2018. Thalassemia, also called Mediterranean anemia, is an inherited and non-infectious blood disorder. (Xinhua/Ahmad Kamal)
The China National Medical Products Administration (NMPA) will review biotech company EdiGene's investigational new drug (IND) application for ET-01, an investigational gene-editing therapy for patients with transfusion-dependent beta-thalassemia (an inherited blood disorder), according to the company's website.
The trial of ET-01 is expected to assess its safety and efficacy in transfusion-dependent beta-thalassemia patients. In China, it is estimated that there are 30 million thalassemia gene carriers, and over 300,000 patients with thalassemia major or thalassemia intermediate. Serious unmet medical needs remain for transfusion-dependent beta-thalassemia patients today.
"We are happy to achieve this important milestone and bring ET-01 closer to clinical-use stage," said Dong Wei, CEO of EdiGene. "We are committed to translating cutting-edge gene-editing technologies into transformative therapies so as to bring patients better choices, and for some, a potential one-time cure. We look forward to receiving approval from NMPA and initiating ET-01 clinical studies in the near future," he added.
ET-01 is an investigational gene-edited hematopoietic stem cell therapy for transfusion dependent beta-thalassemia patients.
EdiGene is a biotech company developing genome editing technologies to accelerate drug discovery and develop novel therapeutics for a wide range of illnesses.
Source: Global Times Published: 2020/10/27 16:38:42
The China National Medical Products Administration (NMPA) will review biotech company EdiGene's investigational new drug (IND) application for ET-01, an investigational gene-editing therapy for patients with transfusion-dependent beta-thalassemia (an inherited blood disorder), according to the company's website.
The trial of ET-01 is expected to assess its safety and efficacy in transfusion-dependent beta-thalassemia patients. In China, it is estimated that there are 30 million thalassemia gene carriers, and over 300,000 patients with thalassemia major or thalassemia intermediate. Serious unmet medical needs remain for transfusion-dependent beta-thalassemia patients today.
"We are happy to achieve this important milestone and bring ET-01 closer to clinical-use stage," said Dong Wei, CEO of EdiGene. "We are committed to translating cutting-edge gene-editing technologies into transformative therapies so as to bring patients better choices, and for some, a potential one-time cure. We look forward to receiving approval from NMPA and initiating ET-01 clinical studies in the near future," he added.
ET-01 is an investigational gene-edited hematopoietic stem cell therapy for transfusion dependent beta-thalassemia patients.
EdiGene is a biotech company developing genome editing technologies to accelerate drug discovery and develop novel therapeutics for a wide range of illnesses.
Beidou2020
SENIOR MEMBER
- Dec 3, 2013
- 7,857
- -48
- Country
- Location
United Imaging Presents Full Portfolio of High-End Medical Imaging Devices at Arab Health 2020
By HospiMedica International staff writers
Posted on 29 Jan 2020
United Imaging (Shanghai, China) made its debut at Arab Health 2020 with a full portfolio of high-end medical imaging devices, including PET/CT, PET/MR, MR, CT, XR and AI products, including Total-body PET/CT, Ultra-wide Bore 3.0T MR and 160-slice CT.
Among its key products showcased United Imaging at the event was the uEXPLORER total-body PET/CT. With the unprecedented axial FOV and system sensitivity, as well as the industry leading spatial resolution, the world’s first total-body PET/CT uEXPLORER not only creates new opportunities for clinical research and patient care, but also shows the strong innovation power of United Imaging.
Image: Total-body PET/CT uEXPLORER (Photo courtesy of United Imaging)
The company highlighted its uMR Omega 3.0T MR system featuring a 75cm ultra-wide bore, making it suitable for bariatric imaging, breast imaging and off-center scan. The technology innovation makes it easy to realize the industry-biggest 60cm FOV and excellent imaging quality with the UIH proprietary uCS imaging platform.
United Imaging also showcased the uCT 780, a 160-slice CT system that is equipped with the fully integrated Z-Detector to allow low dose data acquisition with fine details. Its fast rotation speed of 0.3 second fundamentally improves the cardiac scan quality, while the coordinated control system boosts the speed for scan and reconstruction.
mobile.hospimedica.com
By HospiMedica International staff writers
Posted on 29 Jan 2020
United Imaging (Shanghai, China) made its debut at Arab Health 2020 with a full portfolio of high-end medical imaging devices, including PET/CT, PET/MR, MR, CT, XR and AI products, including Total-body PET/CT, Ultra-wide Bore 3.0T MR and 160-slice CT.
Among its key products showcased United Imaging at the event was the uEXPLORER total-body PET/CT. With the unprecedented axial FOV and system sensitivity, as well as the industry leading spatial resolution, the world’s first total-body PET/CT uEXPLORER not only creates new opportunities for clinical research and patient care, but also shows the strong innovation power of United Imaging.
Image: Total-body PET/CT uEXPLORER (Photo courtesy of United Imaging)
The company highlighted its uMR Omega 3.0T MR system featuring a 75cm ultra-wide bore, making it suitable for bariatric imaging, breast imaging and off-center scan. The technology innovation makes it easy to realize the industry-biggest 60cm FOV and excellent imaging quality with the UIH proprietary uCS imaging platform.
United Imaging also showcased the uCT 780, a 160-slice CT system that is equipped with the fully integrated Z-Detector to allow low dose data acquisition with fine details. Its fast rotation speed of 0.3 second fundamentally improves the cardiac scan quality, while the coordinated control system boosts the speed for scan and reconstruction.
United Imaging Presents Full Portfolio of High-End Medical Imaging Devices at Arab Health 2020
United Imaging (Shanghai, China) made its debut at Arab Health 2020 with a full portfolio of high-end medical imaging devices, including PET/CT, PET/MR, MR, CT, XR and AI products, including Total-body PET/CT, Ultra-wide Bore 3.0T MR and 160-slice CT.
TaiShang
ELITE MEMBER
- Apr 30, 2014
- 27,843
- 70
- Country
- Location
First animal surgery using home-grown robot
Medical experts from Shanghai Chest Hospital completed the nation's first animal lung surgery experi
www.shine.cn
Medical experts from Shanghai Chest Hospital completed the nation’s first animal lung surgery experiment using a single-hole surgical robot developed in China. The experiment stems from clinical research conducted by the hospital and Shanghai Jiao Tong University.
With the development of minimally invasive surgery, thoracic operations via surgical robots have been performed in more than 150 Chinese hospitals — but all with robots developed abroad.
Dr Luo Qingquan from Shanghai Chest Hospital led the animal experiment by operating on a pig. With the robot, doctors were able to remove the pig's right upper lung within one hour with no serious bleeding.
Doctors then used the robot to conduct heart surgery on the same pig, whose vital signs were stable afterward.
Luo said single-hole surgical robots are a hot topic for developers in China and abroad. His team will partner with Chinese developers to create new surgical systems and improve existing ones.
“We will carry out more animal experiments to perfect the system and expedite a clinical trial for it," he said.
Users Who Are Viewing This Thread (Total: 1, Members: 0, Guests: 1)
Similar threads
Pakistan Affairs Latest Posts
-
-
US terms Pakistan 'major' non-Nato ally, Nato partner- Latest: TheSolution
Military Forum Latest Posts
-
-
GE makes breakthrough in detonating hypersonic propulsion- Latest: White and Green with M/S
-
